Skip to main content

Oxford Cannabinoid Technologies "proceeding forward as planned" after review meeting

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) CEO Clarissa Sowemimo-Coker speaks to Proactive after announcing that a Research Ethics Committee (REC) review meeting for its lead programme OCT461201 has now taken place. Sowemimo-Coker says the company is "proceeding forward as planned" and has "hit the ground running" in 2023.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  228.47
+1.58 (0.70%)
AAPL  277.91
+0.02 (0.01%)
AMD  222.88
+1.77 (0.80%)
BAC  54.12
+0.23 (0.42%)
GOOG  315.19
+0.74 (0.23%)
META  657.39
-9.41 (-1.41%)
MSFT  490.97
-0.05 (-0.01%)
NVDA  185.34
-0.22 (-0.12%)
ORCL  220.15
-0.39 (-0.18%)
TSLA  447.97
+8.39 (1.91%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.